Le Lézard
Classified in: Health
Subjects: NPT, LAW, AVO

CAP Files Amicus Brief in Support of ACLA Motion for Summary Judgement in PAMA Lawsuit


WASHINGTON, Feb. 22, 2018 /PRNewswire-USNewswire/ -- The College of American Pathologists (CAP) filed an amicus curiae brief in support of a motion by the American Clinical Laboratory Association (ACLA) for summary judgement to set aside how the Department of Health and Human Services (HHS) implemented market-based reforms to clinical laboratory fees mandated by the Protecting Access to Medicare Act (PAMA) of 2014. The CAP has strongly supported ACLA's lawsuit against the HHS and efforts to correct the administration's execution of PAMA's clinical laboratory payment reforms.

College of American Pathologists

The CAP's amicus brief states that the HHS' definition of applicable laboratory contradicted the PAMA statute. For example, the HHS excluded the vast majority of hospital-based laboratories from its data collection process and calculation of supposedly market-based rates for clinical laboratory services for 2018. In 2017, hospital laboratories accounted for 48.2% of laboratory market share by test volume. However, a mere 1% of the reported test volume came from hospital laboratories when HHS set 2018 Medicare clinical laboratory fee schedule rates.

In PAMA, Congress had required HHS to collect comprehensive and accurate reimbursement data from all independent and hospital-based laboratories that receive most of their Medicare revenues from serving beneficiaries whom are not hospital inpatients or outpatients. 

"The CAP submits this amicus brief to urge the court to require the secretary to consider the full range of laboratory pricing data, including from hospital laboratories, so that Medicare patients may maintain access to laboratory services that are vitally important to their diagnosis, treatment, and care," the CAP said.

The amicus brief was filed in the U.S. District Court for the District of Columbia on February 21. Read the CAP's full amicus brief.

About the College of American Pathologists
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at CAP.org.

SOURCE College of American Pathologists


These press releases may also interest you

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...



News published on and distributed by: